What the buyer wrote
NOTE: This notice was updated on 06 August 2016 for the following reason: Adjustment to description (Section 4) to adjust typing errorsIn vitro metabolism of the API being developed by Dstl and how this will be used to improve the understanding of the drugs as the project moves forwards to be completed to Good Laboratory to clinical trials. API must be completed to Good Laboratory Practice (GLP). Only Suppliers that have the mandatory GLP systems in place should express interest in this requirement. Additional information: To view this notice, register as a supplier here: http://www.contracts.mod.uk/delta/signup.html?userType=supplier and search for the notice with reference 'GB-Sa…
Details
- What the buyer calls it
- GB-Salisbury: Pharma in vitro metabolism
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 29 Sep 2016
- Work ends
- 31 Mar 2017
- Kind of work
- Pharmacy and medicines
Who the buyer named
D Blackmore was the named contact on this notice.